Methodological issues and new developments in the economic evaluation of vaccines
The application of economic evaluation in healthcare, including vaccination programs, hasincreased exponentially since the 1980s.There are a number of aspects of economicevaluation of vaccine programs that present particular challenges to the analyst. Theseinclude the development of the appropriate epidemiological models from which to estimatethe costs and benefits; the accurate prediction of uptake rates; the incorporation of qualifyadjusted survival gains; and the inclusion of intangible but nonetheless important benefits andcosts associated with infectious disease and vaccination. The estimation of marginalintervention costs presents specific difficulties, especially for multivalent vaccines and valuingcosts and benefits over time is heavily influenced by the choice of discount rate, which is still acontroversial topic. Developments in the next 5 years are likely to address all of these issuesand result in more sophisticated and accurate models of vaccination programs.
Year of publication: |
2005
|
---|---|
Authors: | Van Doorslaer Eddy ; Beutels Philippe ; Hall Jane ; Van Damme Pierre |
Publisher: |
International Water Association |
Saved in:
freely available
Saved in favorites
Similar items by person
-
Kenny Patsy, (2004)
-
Economic evaluation of cystic fibrosis screening: A review of the literature
Radhakrishnan Yashin, (2008)
-
Partnerships for knowledge exchange in health services research, policy and practice
Mitchell Penny, (2009)
- More ...